Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

713 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galantamine-memantine hybrids for Alzheimer's disease: The influence of linker rigidity in biological activity and pharmacokinetic properties.
Basagni F, Ortega JA, Bertozzi SM, Armirotti A, Summa M, Bertorelli R, Bartolini M, Mellor IR, Bedeschi M, Bottegoni G, Lembo V, Minarini A, Cavalli A, Rosini M. Basagni F, et al. Among authors: cavalli a. Eur J Med Chem. 2023 Dec 5;261:115803. doi: 10.1016/j.ejmech.2023.115803. Epub 2023 Sep 12. Eur J Med Chem. 2023. PMID: 37734258 Free article.
Isolation and Characterization of Monomeric Human RAD51: A Novel Tool for Investigating Homologous Recombination in Cancer.
Rinaldi F, Schipani F, Balboni B, Catalano F, Marotta R, Myers SH, Previtali V, Veronesi M, Scietti L, Cecatiello V, Pasqualato S, Ortega JA, Girotto S, Cavalli A. Rinaldi F, et al. Among authors: cavalli a. Angew Chem Int Ed Engl. 2023 Dec 18;62(51):e202312517. doi: 10.1002/anie.202312517. Epub 2023 Nov 20. Angew Chem Int Ed Engl. 2023. PMID: 37924230
An 19F NMR fragment-based approach for the discovery and development of BRCA2-RAD51 inhibitors to pursuit synthetic lethality in combination with PARP inhibition in pancreatic cancer.
Myers SH, Poppi L, Rinaldi F, Veronesi M, Ciamarone A, Previtali V, Bagnolini G, Schipani F, Ortega Martínez JA, Girotto S, Di Stefano G, Farabegoli F, Walsh N, De Franco F, Roberti M, Cavalli A. Myers SH, et al. Among authors: cavalli a. Eur J Med Chem. 2024 Feb 5;265:116114. doi: 10.1016/j.ejmech.2023.116114. Epub 2023 Dec 31. Eur J Med Chem. 2024. PMID: 38194775 Free article.
Preomic profile of BxPC-3 cells after treatment with BRC4.
Previtali V, Myers SH, Poppi L, Wynne K, Casamassima I, Girotto S, Di Stefano G, Farabegoli F, Roberti M, Oliviero G, Cavalli A. Previtali V, et al. Among authors: cavalli a. J Proteomics. 2023 Sep 30;288:104983. doi: 10.1016/j.jprot.2023.104983. Epub 2023 Aug 1. J Proteomics. 2023. PMID: 37536521
Exploration of Tools for the Interpretation of Human Non-Coding Variants.
Tabarini N, Biagi E, Uva P, Iovino E, Pippucci T, Seri M, Cavalli A, Ceccherini I, Rusmini M, Viti F. Tabarini N, et al. Among authors: cavalli a. Int J Mol Sci. 2022 Oct 26;23(21):12977. doi: 10.3390/ijms232112977. Int J Mol Sci. 2022. PMID: 36361767 Free PMC article. Review.
Ultrapotent IgA dimeric antibodies neutralize emerging Omicron variants.
Zuo F, Cao Y, Sun R, Wang Q, Simonelli L, Du L, Bertoglio F, Schubert M, Guerra C, Cavalli A, Hust M, Robbiani DF, Varani L, Abolhassani H, Xie XS, Hammarström L, Marcotte H, Pan-Hammarström Q. Zuo F, et al. Among authors: cavalli a. J Virol. 2024 Dec 4:e0174024. doi: 10.1128/jvi.01740-24. Online ahead of print. J Virol. 2024. PMID: 39629995 Free article. No abstract available.
713 results